ClinicalTrials.Veeva

Menu
O

Ormeau Clinical Trials | Belfast, United Kingdom

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Maridebart Cafraglutide
NOC-110
CHF5993
Verekitug
Olpasiran
UPB-101

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 9 total trials

A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older (BEETHOVEN)

The purpose of the study is to learn about how effective, safe, and tolerable the Clostridioides difficile (C. difficile) vaccine is in decreasing th...

Enrolling
Clostridioides Difficile Associated Disease
Biological: C.difficile vaccine
Other: Saline Placebo

The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.

Active, not recruiting
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Drug: Maridebart cafraglutide
Drug: Placebo

The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.

Active, not recruiting
Obesity
Drug: Placebo
Drug: Maridebart Cafraglutide

The primary objective of this trial is to compare the effect of treatment with olpasiran, to placebo, on the risk for coronary heart disease death (C...

Active, not recruiting
Atherosclerotic Cardiovascular Disease
Drug: Olpasiran
Drug: Placebo

This is a phase 2b, randomized, double-blind, placebo-controlled study investigating the efficacy, safety, and tolerability of Taplucainium Inhalatio...

Active, not recruiting
Refractory or Unexplained Chronic Cough
Drug: NOC-110
Other: Placebo

This study will compare an asthma inhaler that uses a new climate friendly alternative propellant to an asthma inhaler with an existing propellant. W...

Enrolling
Asthma
Drug: CHF5993 pMDI with HFA-134a
Drug: CHF5993 pMDI with HFA-152a

Trial sponsors

Amgen logo
Chiesi logo
Daiichi Sankyo logo
N
Pfizer logo
U

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems